1,382 results on '"Wilde, Arthur A M"'
Search Results
2. Are disease-specific patient-reported outcomes measures (PROMs) used in cardiogenetics? A systematic review
3. The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable
4. Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology
5. Human Genetics of Cardiomyopathies
6. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias
7. A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients
8. Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor
9. Timing and mid-term outcomes of using leadless pacemakers as replacement for infected cardiac implantable electronic devices
10. Outcomes in Dutch DPP6 risk haplotype for familial idiopathic ventricular fibrillation: a focused update
11. The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
12. MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
13. SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades
14. Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy
15. Real-world long-term battery longevity of Micra leadless pacemakers
16. Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?
17. Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci
18. Prognosis and clinical management of asymptomatic family members with RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: a review
19. Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter‐Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO‐IT)) Registry
20. A deep learning approach identifies new ECG features in congenital long QT syndrome
21. How to study the role of volunteer responders in the chain of survival
22. Genetic testing in early-onset atrial fibrillation.
23. Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study.
24. Clinical utility gene card for: Long-QT syndrome
25. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study
26. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
27. Age, Sex and Racial Differences in Cardiac Repolarization and Arrhythmogenesis
28. Listen to Your Patient and Act on the Triggers
29. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
30. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
31. Are disease-specific patient-reported outcomes measures (PROMs) used in cardiogenetics? A systematic review
32. The Genetic Basis of Apparently Idiopathic Ventricular Fibrillation – a Retrospective Overview
33. TGFBR1 Variants Can Associate with Non-Syndromic Congenital Heart Disease without Aortopathy
34. Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome
35. Risk scores in congenital long QT syndrome: friend or foe?
36. Epidemiology of inherited arrhythmias
37. The yield of postmortem genetic testing in sudden death cases with structural findings at autopsy
38. Inherited Arrhythmias: Brugada Syndrome and Early Repolarisation Syndrome
39. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
40. Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.
41. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports
42. Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation
43. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
44. Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry
45. Risk stratification of sudden cardiac death: a review
46. Manual versus Automatic Assessment of the QT-Interval and QTc
47. Diagnostic Accuracy of the Standing Test in Adults Suspected for Congenital Long‐QT Syndrome
48. Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review
49. A Potential Diagnostic Approach for Foetal Long-QT Syndrome, Developed and Validated in Children
50. Inherited cardiac arrhythmias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.